Evidence map›Paper›PMID 36149944›Full record

ArticleBlood advances2023

Germline SNPs previously implicated as prognostic biomarkers do not associate with outcomes in intensively treated AML.

Aarif M N Batcha, Nele Buckup, Stefanos A Bamopoulos, Vindi Jurinovic, Maja Rothenberg-Thurley, Hanna Gittinger, Bianka Ksienzyk, Annika Dufour, Stephanie Schneider, Mika Kontro and 13 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 80% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 9 institutions in 2 countries.

Aarif M N BatchaInstitute for Medical Information Processing, Biometry and Epidemiology, LMU Munich, Munich, Germany.ORCID 0000-0002-7972-7506
Nele BuckupDepartment of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.
Stefanos A BamopoulosDepartment of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0002-5997-7735
Vindi JurinovicInstitute for Medical Information Processing, Biometry and Epidemiology, LMU Munich, Munich, Germany.
Maja Rothenberg-ThurleyDepartment of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.
Hanna GittingerDepartment of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.
Bianka KsienzykDepartment of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.
Annika DufourDepartment of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.
Stephanie SchneiderDepartment of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.
Mika KontroDepartment of Haematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
Joseph SaadInstitute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.ORCID 0000-0001-7701-0328
Caroline A HeckmannInstitute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.ORCID 0000-0002-4324-8706
Cristina SauerlandInstitute of Biostatistics and Clinical Research, University of Münster, Münster, Germany.
Dennis GörlichInstitute of Biostatistics and Clinical Research, University of Münster, Münster, Germany.ORCID 0000-0002-2574-9419
Wolfgang E BerdelDepartment of Medicine A, Hematology and Oncology, University of Münster, Münster, Germany.ORCID 0000-0002-3030-6567
Bernhard J WörmannGerman Society of Hematology and Oncology, Berlin, Germany.
Utz KrugDepartment of Medicine III, Hospital Leverkusen, Leverkusen, Germany.
Jan BraessDepartment of Oncology and Hematology, Hospital Barmherzige Brüder, Regensburg, Germany.
Ulrich MansmannInstitute for Medical Information Processing, Biometry and Epidemiology, LMU Munich, Munich, Germany.ORCID 0000-0002-9955-8906
Wolfgang HiddemannDepartment of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.
Karsten SpiekermannDepartment of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0002-5139-4957
Klaus H MetzelerDepartment of Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany.ORCID 0000-0003-3920-7490
Tobias HeroldDepartment of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0002-9615-9432
Munich Leukemia Laboratory (Germany) · DEGerman Cancer Research Center · DEUniversity of Helsinki · FIUniversity of Münster · DEKlinikum Leverkusen · DEKrankenhaus Barmherzige Brüder · DELMU Klinikum · DEUniversity Hospital Leipzig · DEZimmer Biomet (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Myeloid, AcutePolymorphism, Single NucleotideBiomarkers, TumorHumansPrognosisBiomarkers, Tumor

Identifiers

PMID36149944
PMCPMC10036512
OpenAlexW4297016641

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.